Treatment tolerability and adherence
Related entities
Findings (27)
None
adverseThe pessary group had significantly higher attrition (26% at 3 months) compared to behavioral therapy (15%) and combined therapy (12%), with vaginal discharge reported by 16% of pessary users. Only 45
Effect: adverse; 26% dropout at 3 months for pessary vs 15% behavioral vs 12% combined
None
adverseThe pessary group had significantly higher attrition (26% at 3 months) compared to behavioral therapy (15%) and combined therapy (12%), with vaginal discharge reported by 16% of pessary users. Only 45
Effect: adverse; 26% dropout at 3 months for pessary vs 15% behavioral vs 12% combined
None
adverseThe pessary group had significantly higher attrition (26% at 3 months) compared to behavioral therapy (15%) and combined therapy (12%), with vaginal discharge reported by 16% of pessary users. Only 45
Effect: adverse; 26% dropout at 3 months for pessary vs 15% behavioral vs 12% combined
None
adverseThe pessary group had significantly higher attrition (26% at 3 months) compared to behavioral therapy (15%) and combined therapy (12%), with vaginal discharge reported by 16% of pessary users. Only 45
Effect: adverse; 26% dropout at 3 months for pessary vs 15% behavioral vs 12% combined
None
adverseThe pessary group had significantly higher attrition (26% at 3 months) compared to behavioral therapy (15%) and combined therapy (12%), with vaginal discharge reported by 16% of pessary users. Only 45
Effect: adverse; 26% dropout at 3 months for pessary vs 15% behavioral vs 12% combined
None
adverseThe pessary group had significantly higher attrition (26% at 3 months) compared to behavioral therapy (15%) and combined therapy (12%), with vaginal discharge reported by 16% of pessary users. Only 45
Effect: adverse; 26% dropout at 3 months for pessary vs 15% behavioral vs 12% combined
None
adverseThe pessary group had significantly higher attrition (26% at 3 months) compared to behavioral therapy (15%) and combined therapy (12%), with vaginal discharge reported by 16% of pessary users. Only 45
Effect: adverse; 26% dropout at 3 months for pessary vs 15% behavioral vs 12% combined
None
adverseThe pessary group had significantly higher attrition (26% at 3 months) compared to behavioral therapy (15%) and combined therapy (12%), with vaginal discharge reported by 16% of pessary users. Only 45
Effect: adverse; 26% dropout at 3 months for pessary vs 15% behavioral vs 12% combined
None
adverseThe pessary group had significantly higher attrition (26% at 3 months) compared to behavioral therapy (15%) and combined therapy (12%), with vaginal discharge reported by 16% of pessary users. Only 45
Effect: adverse; 26% dropout at 3 months for pessary vs 15% behavioral vs 12% combined
None
adverseThe pessary group had significantly higher attrition (26% at 3 months) compared to behavioral therapy (15%) and combined therapy (12%), with vaginal discharge reported by 16% of pessary users. Only 45
Effect: adverse; 26% dropout at 3 months for pessary vs 15% behavioral vs 12% combined
None
adverseThe pessary group had significantly higher attrition (26% at 3 months) compared to behavioral therapy (15%) and combined therapy (12%), with vaginal discharge reported by 16% of pessary users. Only 45
Effect: adverse; 26% dropout at 3 months for pessary vs 15% behavioral vs 12% combined
None
adverseThe pessary group had significantly higher attrition (26% at 3 months) compared to behavioral therapy (15%) and combined therapy (12%), with vaginal discharge reported by 16% of pessary users. Only 45
Effect: adverse; 26% dropout at 3 months for pessary vs 15% behavioral vs 12% combined
None
adverseThe pessary group had significantly higher attrition (26% at 3 months) compared to behavioral therapy (15%) and combined therapy (12%), with vaginal discharge reported by 16% of pessary users. Only 45
Effect: adverse; 26% dropout at 3 months for pessary vs 15% behavioral vs 12% combined
None
adverseThe pessary group had significantly higher attrition (26% at 3 months) compared to behavioral therapy (15%) and combined therapy (12%), with vaginal discharge reported by 16% of pessary users. Only 45
Effect: adverse; 26% dropout at 3 months for pessary vs 15% behavioral vs 12% combined
None
adverseThe pessary group had significantly higher attrition (26% at 3 months) compared to behavioral therapy (15%) and combined therapy (12%), with vaginal discharge reported by 16% of pessary users. Only 45
Effect: adverse; 26% dropout at 3 months for pessary vs 15% behavioral vs 12% combined
None
adverseThe pessary group had significantly higher attrition (26% at 3 months) compared to behavioral therapy (15%) and combined therapy (12%), with vaginal discharge reported by 16% of pessary users. Only 45
Effect: adverse; 26% dropout at 3 months for pessary vs 15% behavioral vs 12% combined
None
adverseThe pessary group had significantly higher attrition (26% at 3 months) compared to behavioral therapy (15%) and combined therapy (12%), with vaginal discharge reported by 16% of pessary users. Only 45
Effect: adverse; 26% dropout at 3 months for pessary vs 15% behavioral vs 12% combined
None
adverseThe pessary group had significantly higher attrition (26% at 3 months) compared to behavioral therapy (15%) and combined therapy (12%), with vaginal discharge reported by 16% of pessary users. Only 45
Effect: adverse; 26% dropout at 3 months for pessary vs 15% behavioral vs 12% combined
None
adverseThe pessary group had significantly higher attrition (26% at 3 months) compared to behavioral therapy (15%) and combined therapy (12%), with vaginal discharge reported by 16% of pessary users. Only 45
Effect: adverse; 26% dropout at 3 months for pessary vs 15% behavioral vs 12% combined
None
adverseThe pessary group had significantly higher attrition (26% at 3 months) compared to behavioral therapy (15%) and combined therapy (12%), with vaginal discharge reported by 16% of pessary users. Only 45
Effect: adverse; 26% dropout at 3 months for pessary vs 15% behavioral vs 12% combined
None
adverseThe pessary group had significantly higher attrition (26% at 3 months) compared to behavioral therapy (15%) and combined therapy (12%), with vaginal discharge reported by 16% of pessary users. Only 45
Effect: adverse; 26% dropout at 3 months for pessary vs 15% behavioral vs 12% combined
None
adverseThe pessary group had significantly higher attrition (26% at 3 months) compared to behavioral therapy (15%) and combined therapy (12%), with vaginal discharge reported by 16% of pessary users. Only 45
Effect: adverse; 26% dropout at 3 months for pessary vs 15% behavioral vs 12% combined
None
adverseThe pessary group had significantly higher attrition (26% at 3 months) compared to behavioral therapy (15%) and combined therapy (12%), with vaginal discharge reported by 16% of pessary users. Only 45
Effect: adverse; 26% dropout at 3 months for pessary vs 15% behavioral vs 12% combined
None
adverseThe pessary group had significantly higher attrition (26% at 3 months) compared to behavioral therapy (15%) and combined therapy (12%), with vaginal discharge reported by 16% of pessary users. Only 45
Effect: adverse; 26% dropout at 3 months for pessary vs 15% behavioral vs 12% combined
None
adverseThe pessary group had significantly higher attrition (26% at 3 months) compared to behavioral therapy (15%) and combined therapy (12%), with vaginal discharge reported by 16% of pessary users. Only 45
Effect: adverse; 26% dropout at 3 months for pessary vs 15% behavioral vs 12% combined
None
adverseThe pessary group had significantly higher attrition (26% at 3 months) compared to behavioral therapy (15%) and combined therapy (12%), with vaginal discharge reported by 16% of pessary users. Only 45
Effect: adverse; 26% dropout at 3 months for pessary vs 15% behavioral vs 12% combined
None
adverseThe pessary group had significantly higher attrition (26% at 3 months) compared to behavioral therapy (15%) and combined therapy (12%), with vaginal discharge reported by 16% of pessary users. Only 45
Effect: adverse; 26% dropout at 3 months for pessary vs 15% behavioral vs 12% combined